Clinical Trials Browser

Phase 2 × Recruiting × Infusions, Intravenous × Clear all

NCT07530445 2026-04-15

Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer

Phase 2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT07286253 2025-12-16

QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial

Phase 2 Recruiting

Neoadjuvant Treatment for Locally Advanced Cervical Cancer